Search Results - "ATHANASIOS DIMOPOULOS, MELETIOS"
-
1
Predictors of adverse prognosis in COVID‐19: A systematic review and meta‐analysis
Published in European journal of clinical investigation (01-10-2020)“…Background Identification of reliable outcome predictors in coronavirus disease 2019 (COVID‐19) is of paramount importance for improving patient's management…”
Get full text
Journal Article -
2
Association of COVID‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection
Published in European journal of heart failure (01-11-2021)“…Aims SARS‐CoV‐2 infection may lead to endothelial and vascular dysfunction. We investigated alterations of arterial stiffness, endothelial coronary and…”
Get full text
Journal Article -
3
Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations
Published in Endocrine (01-12-2021)“…Overweight, obesity, and metabolic syndrome (MetS) have become epidemic conditions affecting 39%, 13%, and 20% of the population respectively. The aim of this…”
Get full text
Journal Article -
4
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation
Published in The oncologist (Dayton, Ohio) (01-06-2017)“…The landscape of local and systemic therapy of renal cell carcinoma (RCC) is rapidly changing. The increase in the incidental finding of small renal tumors has…”
Get full text
Journal Article -
5
XBB.1.5 neutralizing antibodies upon bivalent COVID‐19 vaccination are similar to XBB but lower than BQ.1.1
Published in American journal of hematology (01-05-2023)Get full text
Journal Article -
6
The emerging role of capivasertib in breast cancer
Published in Breast (Edinburgh) (01-06-2022)“…Over 50% of breast tumors harbor alterations in one or more genes of the phosphatidylinositol 3-kinase (PI3K) pathway including PIK3CA mutations (31%), PTEN…”
Get full text
Journal Article -
7
Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine
Published in British journal of haematology (01-01-2022)“…Summary Patients with multiple myeloma (MM) have a suboptimal antibody response following vaccination against severe acute respiratory syndrome coronavirus 2…”
Get full text
Journal Article -
8
Trastuzumab administration during pregnancy: un update
Published in BMC cancer (26-04-2021)“…Background Over than one third (28-58%) of pregnancy-associated breast cancer (PABC) cases are characterized by positive epidermal growth factor receptor…”
Get full text
Journal Article -
9
Distinct neutralization profile of spike variants by antibodies induced upon SARS‐CoV‐2 infection or vaccination
Published in American journal of hematology (01-01-2022)Get full text
Journal Article -
10
Cardiovascular toxicity of breast cancer treatment: an update
Published in Cancer chemotherapy and pharmacology (01-07-2021)“…Novel chemotherapeutic agents have marked a new era in oncology during the past decade, prolonging significantly the overall survival of breast cancer…”
Get full text
Journal Article -
11
Belantamab mafodotin induces immunogenic cell death within 24 h post‐administration in newly diagnosed multiple myeloma patients
Published in American journal of hematology (01-03-2023)Get full text
Journal Article -
12
Clinical perspectives of BET inhibition in ovarian cancer
Published in Cellular oncology (Dordrecht) (01-04-2021)“…Background Bromodomain and extra-terminal (BET) proteins are epigenetic readers that bind to acetylated lysines of histones and regulate gene transcription…”
Get full text
Journal Article -
13
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group
Published in American journal of hematology (01-05-2023)“…We evaluated the efficacy and prognostic impact of bortezomib‐lenalidomide triplet (VRd) or daratumumab‐based quadruplets (DBQ) versus previous anti‐myeloma…”
Get full text
Journal Article -
14
Metabolomics Point out the Effects of Carfilzomib on Aromatic Amino Acid Biosynthesis and Degradation
Published in International journal of molecular sciences (01-09-2023)“…(1) Carfilzomib (Cfz) is an antineoplastic agent indicated for the treatment of multiple myeloma. However, its beneficial action is attenuated by the…”
Get full text
Journal Article -
15
An Untargeted Metabolomics Approach on Carfilzomib-Induced Nephrotoxicity
Published in Molecules (Basel, Switzerland) (01-11-2022)“…Carfilzomib (Cfz) is an anti-cancer drug related to cardiorenal adverse events, with cardiovascular and renal complications limiting its clinical use. Despite…”
Get full text
Journal Article -
16
Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
Published in Journal of hematology and oncology (31-05-2021)“…Vaccination for SARS-CoV-2 provides significant protection against the infection in the general population. However, only limited data exist for patients with…”
Get full text
Journal Article -
17
Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection
Published in Frontiers in immunology (26-11-2021)“…Durability of SARS-CoV-2 Spike antibody responses after infection provides information relevant to understanding protection against COVID-19 in humans. We…”
Get full text
Journal Article -
18
Real-World Effectiveness and Safety of Belantamab Mafodotin Monotherapy in Triple-Class Refractory Multiple Myeloma
Published in International journal of molecular sciences (01-07-2023)“…B-cell maturation antigen (BCMA) is a promising therapeutic target for multiple myeloma (MM). The aim of this study was to assess the effectiveness and…”
Get full text
Journal Article -
19
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome
Published in British journal of cancer (01-01-2022)“…Background Despite significant advances in multiple myeloma (MM) therapy, disease relapse and treatment resistance remain major obstacles in clinical…”
Get full text
Journal Article -
20
The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic Review
Published in Frontiers in oncology (11-09-2020)“…Breast cancer is the most common malignancy diagnosed during pregnancy. Strong data on the genomic profile of pregnancy-associated breast cancer are lacking…”
Get full text
Journal Article